石药集团(01093.HK):SYS6088注射液用于治疗晚期实体瘤的 I/II期临床试验在中国首个研究中心正式启动

智通财经
Nov 03
【石药集团(01093.HK):SYS6088注射液用于治疗晚期实体瘤的 I/II期临床试验在中国首个研究中心正式启动】智通财经APP讯,石药集团(01093.HK)发布公告,本集团开发的SYS6088注射液(该产品)用于治疗晚期实体瘤的I/II期临床试验(SYS6088-001)已在中国首个研究中心正式启动。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10